Harrow- 11.875% NT REDEEM 31/12/2027 USD 25 Minority Interest

As of the most recent data (June 2026), HROWM shows a minority interest of $-360K. That compares with $-360K in the prior-year period — up 0.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HROWM's minority interest is now $-360K (was $-360K) — essentially flat versus a year earlier. Pairing that YoY change with peer averages gives a clearer picture of whether Harrow- 11.875% NT REDEEM 31/12/2027 USD 25 is outperforming or lagging.

Tracking HROWM's minority interest over time shows whether Harrow- 11.875% NT REDEEM 31/12/2027 USD 25 is scaling, shrinking, or reshaping that part of the business. The current reading is $-360K That compares with $-360K in the prior-year period — up 0.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this minority interest page, Stockcircle has Harrow- 11.875% NT REDEEM 31/12/2027 USD 25's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect minority interest (currently $-360K) with ownership activity and broader fundamentals.

Harrow- 11.875% NT REDEEM 31/12/2027 USD 25's minority interest is $-360K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.